Wedbush Securities Inc Aravive, Inc. Transaction History

Wedbush Securities Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$4.36 - $6.51 $96,356 - $143,871	-22,100 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$4.7 - $12.06 $23,030 - $59,094	-4,900 Reduced 18.15%	22,100 $104,000
Q2 2020 Jul 16, 2020	BUY	$5.18 - $14.81 $57,498 - $164,391	11,100 Added 69.81%	27,000 $314,000
Q1 2020 Apr 17, 2020	BUY	$3.5 - $13.77 $55,650 - $218,943	15,900 New	15,900 $92,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.